top of page

English News Releases

Limaca Medical and HekaBio Announce Japan Partnership May 17, 2022

Limaca Medical and HekaBio Announce Japan Partnership May 17, 2022

Limaca Medical and HekaBio Announce Japan Partnership May 17, 2022

2022年5月17日

Alpha Tau Medical (DRTS) rings the bell at NASDAQ Apr. 11, 2022

Alpha Tau Medical (DRTS) rings the bell at NASDAQ Apr. 11, 2022

Alpha Tau Medical (DRTS) rings the bell at NASDAQ Apr. 11, 2022

2022年4月11日

Completion of HB-001 Open Label Study in Japan Jan. 11, 2022

Completion of HB-001 Open Label Study in Japan Jan. 11, 2022

Completion of HB-001 Open Label Study in Japan Jan. 11, 2022

2022年1月11日

Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM Oct. 12, 2021

Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM Oct. 12, 2021

Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM Oct. 12, 2021

2021年10月12日

Alpha Tau & Healthcare Capital Corp. to Combine and Create A $1-Billion Publicly Traded Company Jul. 13, 2021

Alpha Tau & Healthcare Capital Corp. to Combine and Create A $1-Billion Publicly Traded Company Jul. 13, 2021

Alpha Tau & Healthcare Capital Corp. to Combine and Create A $1-Billion Publicly Traded Company Jul. 13, 2021

2021年7月13日

HekaBio Enters Licensing and Commercialization Agreement with SalutarisMD Jul. 9, 2021

HekaBio Enters Licensing and Commercialization Agreement with SalutarisMD Jul. 9, 2021

HekaBio Enters Licensing and Commercialization Agreement with SalutarisMD Jul. 9, 2021

2021年7月9日

トップページへ

bottom of page